Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Abstract: Unmanned aerial vehicles (UAVs) offer a means to relay signals around obstacles in millimeter wave (mmWave) mobile ad hoc networks. Achieving these benefits, however, requires a dynamic beam ...
WVE Wave Life Sciences Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results